Literature DB >> 17761967

More support for the judicious use of high-dose interleukin-2 in patients with advanced melanoma.

David F McDermott, Michael B Atkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761967     DOI: 10.1200/JCO.2007.11.9552

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Chemotherapy in the management of advanced cutaneous malignant melanoma.

Authors:  Jason J Luke; Gary K Schwartz
Journal:  Clin Dermatol       Date:  2013 May-Jun       Impact factor: 3.541

Review 2.  [Experimental treatment of malignant melanoma and its rationale].

Authors:  K Rass; M Diefenbacher; W Tilgen
Journal:  Hautarzt       Date:  2008-06       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.